Q/C Technologies, Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Q/C Technologies, Inc. stock issued during period, value, issued for services for the quarter ending 2021-09-30 was $90.00K.
- Q/C Technologies, Inc. stock issued during period, value, issued for services for the quarter ending 2019-09-30 was $119.78K.
- Q/C Technologies, Inc. stock issued during period, value, issued for services for the quarter ending 2019-06-30 was $118.48K.
- Q/C Technologies, Inc. stock issued during period, value, issued for services for the quarter ending 2019-03-31 was $3.91K, a 68.86% decline year-over-year.
- Q/C Technologies, Inc. stock issued during period, value, issued for services for fiscal 2025 was $101.30K, a 83.12% decline from fiscal 2024.
- Q/C Technologies, Inc. stock issued during period, value, issued for services for fiscal 2024 was $600.00K.
- Q/C Technologies, Inc. stock issued during period, value, issued for services for fiscal 2021 was $90.00K.
- Q/C Technologies, Inc. stock issued during period, value, issued for services for fiscal 2019 was $10.80K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2025-12-31 | $101.30K 10-K · filed 2026-04-15 | |
| 2024-12-31 | $600.00K 10-K · filed 2026-04-15 | |
| 2021-12-31 | $90.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $90.00K 10-Q · filed 2022-11-10 | |
| 2019-12-31 | $10.80K 10-K · filed 2021-03-01 | |
| 2019-09-30 | $119.78K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $118.48K 10-Q · filed 2019-11-14 | |
| 2019-03-31 | $3.91K 10-Q · filed 2019-11-14 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $12.54K derived: sum of 4 quarters · filed 2019-04-01 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $12.54K derived: sum of 4 quarters · filed 2019-04-01 |
| 2018-03-31 | $12.54K 10-Q · filed 2018-07-13 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2019-04-01 | $5.46K 10-K · filed 2019-04-01 |
| 2017-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-07-13 | |
| 2016-09-30 | $15.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | |
| 2016-06-30 | $16.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | |
| 2016-03-31 | -$8.24K 10-Q · filed 2016-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |